Comvita Limited (CVNZF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Comvita Limited (CVNZF) trades at $0.40 with AI Score 41/100 (Grade C). Comvita Limited is a New Zealand-based global producer and distributor of natural wellness products, specializing in Manuka honey, propolis, and olive leaf extract. Market cap: $29.10M, Sector: Consumer defensive.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CVNZF: CVNZF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CVNZF against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CVNZF: the 1 perspectives are evenly split.
How is this calculated? →Comvita Limited (CVNZF) Consumer Business Overview
Comvita Limited, established in 1974 and headquartered in New Zealand, is a global producer and distributor of natural wellness products, specializing in Manuka honey, propolis, and olive leaf extract. Operating across multiple continents, the company manages apiaries and intellectual property, serving the growing consumer demand for natural health solutions.
What Is the Investment Thesis for CVNZF?
Comvita Limited operates within the expanding global natural health and wellness market, driven by increasing consumer demand for natural and sustainably sourced products. The company's core strength lies in its established brand and expertise in Manuka honey, a premium product with recognized health benefits. With a gross margin of 42.3%, Comvita demonstrates efficiency in its production and supply chain for these specialized products. The company's extensive international distribution network, spanning Australia, New Zealand, China, North America, Europe, and other regions, positions it to capitalize on global market trends. However, the company currently faces profitability challenges, indicated by a profit margin of -44.5%, which necessitates careful monitoring of operational efficiency and cost management. Key growth catalysts include the continued global expansion of Manuka honey demand, diversification into complementary natural wellness products, and strategic market penetration in high-growth regions. Investors should assess the company's ability to navigate environmental factors impacting bee populations and honey production yields, which pose ongoing supply chain risks, while leveraging its intellectual property and apiary ownership to maintain product quality and supply.
Based on FMP financials and quantitative analysis
CVNZF Key Highlights
- Market capitalization of $29.10M reflects its current valuation within the specialized natural wellness sector.
- Gross margin of 42.3% indicates strong profitability at the product level, exceeding many industry benchmarks for packaged goods.
- Profit margin of -44.5% highlights current operational challenges impacting overall profitability.
- A Beta of 0.27 suggests lower volatility compared to the broader market, potentially appealing to risk-averse investors.
- The company employs 400 individuals, indicating a substantial operational footprint for a specialized natural product company.
Who Are CVNZF's Competitors?
CVNZF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GPAGF Gruma, S.A.B. de C.V. | $18.50 | +2.21% | $6.31B | 66 |
| PNGAF Pangea Wellness Inc. | $0.37 | +10.51% | $5.54M | 65 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.75M | 64 |
| BOF BranchOut Food Inc. | $4.58 | -4.18% | $70.15M | 61 |
| WESTW Westrock Coffee Company, LLC | $1.92 | +29.73% | $168.42M | 51 |
| PTCXF PT Wilmar Cahaya Indonesia Tbk. | $0.11 | +0.00% | $70.48M | 51 |
| DAR Darling Ingredients Inc. | $57.49 | +1.70% | $9.14B | 51 |
| ASBFF Associated British Foods plc | $25.14 | +0.00% | $17.59B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CVNZF's Key Strengths?
- Established global brand with strong recognition in natural wellness, especially Manuka honey.
- Vertical integration through owned apiaries ensures quality control and supply chain stability for key ingredients.
- Diverse product portfolio beyond honey, including propolis, olive leaf extract, and specialized health lines.
- Extensive international distribution network across multiple continents.
- Significant intellectual property in natural product formulations.
What Are CVNZF's Weaknesses?
- Negative profit margin of -44.5% indicates current profitability challenges.
- Reliance on natural resources (bee populations, honey yields) makes it susceptible to environmental factors.
- Operating in the OTC market may lead to lower liquidity and less stringent disclosure requirements.
- Beta of 0.27 suggests potentially lower investor interest or perceived growth compared to higher-beta stocks.
- Unknown disclosure status on the OTC market could deter some institutional investors.
What Could Drive CVNZF Stock Higher?
- **Expansion in Key International Markets:** Focused efforts to deepen market penetration in high-growth regions like China and North America, potentially through new distribution partnerships or enhanced e-commerce strategies, could drive significant revenue growth.
- **Increasing Global Demand for Natural Wellness Products:** The sustained consumer trend towards natural health remedies and preventative wellness products, particularly Manuka honey, continues to provide a tailwind for Comvita's core offerings.
- **Product Diversification and Innovation:** The introduction of new product lines or enhanced formulations within its propolis, olive leaf extract, or specialized honey segments could broaden its market appeal and revenue streams.
- **Leveraging Vertical Integration:** Continued optimization of its apiary management and supply chain for Manuka honey can ensure consistent quality and supply, reinforcing its premium market position and potentially improving margins.
- **Strategic Digital Transformation:** Investments in e-commerce platforms and digital marketing to enhance direct-to-consumer sales could lead to improved profitability and customer engagement.
What Are the Key Risks for CVNZF?
- Financial-distress signal — its Altman Z-Score of 1.39 sits in the distress zone (elevated bankruptcy risk).
- **Environmental Factors Impacting Bee Populations:** Adverse environmental conditions, diseases, or climate change could severely impact bee populations and Manuka honey production yields, directly affecting Comvita's primary revenue source.
- **Negative Profit Margin:** The reported -44.5% profit margin indicates significant operational or cost challenges that, if not addressed effectively, could threaten long-term financial viability.
- **Supply Chain Disruptions:** Global supply chain vulnerabilities, including sourcing of raw materials or international logistics, could lead to increased costs and inability to meet demand.
- **Intense Competition in Natural Wellness Market:** The natural health and wellness sector is competitive, with both specialized and large consumer goods companies vying for market share, potentially pressuring Comvita's pricing and market position.
- **OTC Market Liquidity and Transparency:** Trading on the OTC Other tier carries risks of lower liquidity, wider bid-ask spreads, and less stringent disclosure requirements, which could impact investor confidence and stock valuation.
What Are the Growth Opportunities for CVNZF?
- **Expanding Global Demand for Manuka Honey:** The global market for Manuka honey continues to expand, driven by increasing scientific recognition of its unique antibacterial and anti-inflammatory properties, alongside growing consumer preference for natural health remedies. Comvita, as a leading producer with established apiaries and intellectual property, is well-positioned to capitalize on this trend. The market is projected to grow significantly in regions like China, North America, and Europe, where health-conscious consumers are willing to pay a premium for high-quality, authenticated Manuka products. By focusing on brand education and expanding distribution channels, Comvita can capture a larger share of this growing market, potentially increasing revenue streams over the next 3-5 years.
- **Diversification into Adjacent Natural Wellness Products:** Beyond Manuka honey, Comvita's portfolio includes propolis, olive leaf extract, and various health-focused elixirs and lozenges. The broader natural wellness market, encompassing supplements, functional foods, and natural skincare, presents substantial opportunities for product line expansion and innovation. By leveraging its expertise in natural ingredients and its established supply chain, Comvita can introduce new products that address specific health concerns like digestive health, immune support, and natural skincare. This diversification strategy can reduce reliance on a single product category and tap into multiple high-growth segments within the natural health industry, with potential market impacts within 2-4 years.
- **Strategic Geographic Expansion and Market Penetration:** Comvita already boasts a wide international presence, including Australia, New Zealand, China, other Asian nations, North America, Europe, the Middle East, and Africa. Focused expansion within these high-growth markets, particularly China and North America, offers significant potential. China's burgeoning middle class and increasing health consciousness present a substantial market for premium natural products, while North America continues to be a leader in natural health product consumption. By strengthening distribution networks, enhancing e-commerce capabilities, and tailoring marketing strategies to local preferences, Comvita can deepen its market penetration and capture new customer segments, driving revenue growth over the next 3-5 years.
- **Enhancing E-commerce and Direct-to-Consumer (DTC) Channels:** The shift towards online retail and direct-to-consumer models offers Comvita an opportunity to improve margins and build stronger customer relationships. Investing in robust e-commerce platforms, digital marketing, and personalized customer experiences can expand its reach beyond traditional retail channels. A strong DTC strategy allows for direct feedback, faster product innovation, and more efficient inventory management. This approach can also help in building brand loyalty and educating consumers directly about the unique benefits of its natural products, potentially yielding significant returns on investment within 1-3 years.
- **Innovation in Product Applications and Research & Development:** Comvita's ownership of apiaries and intellectual property provides a foundation for continued research and development into new applications for Manuka honey, propolis, and olive leaf extract. This could include developing new medical-grade products, advanced skincare formulations, or novel functional food ingredients. Investing in R&D allows the company to differentiate its offerings, secure new patents, and maintain a competitive edge in the rapidly evolving natural products market. Such innovations can open up new revenue streams and market segments, ensuring long-term relevance and growth, with potential product launches and market entry within 4-6 years.
What Opportunities Does CVNZF Have?
- Growing global consumer interest in natural health and wellness products.
- Expansion into new geographic markets or deeper penetration in existing high-growth regions like China and North America.
- Further product diversification and innovation within the natural health and skincare segments.
- Leveraging e-commerce and direct-to-consumer channels to improve margins and customer engagement.
- Potential for strategic partnerships or acquisitions to expand product offerings or market reach.
What Threats Does CVNZF Face?
- Environmental factors such as climate change, disease, or pesticide use impacting bee populations and honey production.
- Intense competition from other natural health product companies and larger consumer goods players.
- Fluctuations in raw material costs and supply chain disruptions.
- Regulatory changes or increased scrutiny on natural health claims and product labeling.
- Economic downturns impacting consumer discretionary spending on premium natural products.
What Are CVNZF's Competitive Advantages?
- **Brand Recognition and Trust:** Comvita has an established brand reputation, particularly for Manuka honey, built over decades since its founding in 1974, fostering consumer trust in its natural wellness products.
- **Vertical Integration and Apiary Ownership:** Ownership and management of apiaries provide control over the quality, authenticity, and supply of key raw materials like Manuka honey, differentiating it from competitors reliant solely on external sourcing.
- **Intellectual Property and Product Formulation:** The company holds significant intellectual property related to its natural product formulations and processes, offering a competitive edge in developing unique and effective wellness solutions.
- **Global Distribution Network:** An extensive international distribution network across multiple continents allows Comvita to reach a diverse customer base and capitalize on global demand for natural health products.
- **Product Diversification:** A broad portfolio beyond just Manuka honey, including propolis, olive leaf extract, and specialized health lines, diversifies revenue streams and caters to a wider range of consumer needs.
What Does CVNZF Do?
Comvita Limited, in conjunction with its affiliated entities, operates on an international scale, concentrating on the creation and distribution of a diverse range of natural wellness products. The company was established in 1974 and is headquartered in Te Puke, New Zealand, where it began its journey to become a prominent player in the natural health sector. Its extensive offerings encompass renowned items like Manuka honey, which is a key product line known for its unique properties, propolis, and olive leaf extract. Beyond these core ingredients, Comvita also provides specialized honey varieties, including Medihoney for therapeutic applications and gourmet options for culinary use. The product portfolio further extends to elixirs, lozenges, and dedicated lines for oral hygiene and children's health, catering to a broad spectrum of consumer needs. Moreover, Comvita develops solutions addressing various health concerns such as digestive well-being, skincare, cardiovascular support, and immune system enhancement, aligning with the growing consumer interest in natural health and wellness products. Beyond its product business, the enterprise manages and owns apiaries, which are crucial for its honey production, possesses real estate holdings, and controls significant intellectual property related to its natural product formulations and processes. Comvita Limited serves markets across Australia, New Zealand, China, other Asian nations, North America, Europe, the Middle East, and Africa, demonstrating a robust global footprint with approximately 400 employees supporting its international operations.
What Products and Services Does CVNZF Offer?
- Produce and distribute Manuka honey, known for its unique health properties.
- Offer specialized honey varieties, including Medihoney for therapeutic use and gourmet options.
- Manufacture propolis-based products, leveraging its natural benefits.
- Develop and sell olive leaf extract products for various health applications.
- Create elixirs and lozenges for general wellness and specific health concerns.
- Provide dedicated product lines for oral hygiene and children's health.
- Formulate solutions for digestive well-being, skincare, cardiovascular support, and immune system enhancement.
- Manage and own apiaries, ensuring control over honey production and quality.
How Does CVNZF Make Money?
- Sourcing raw materials (honey, propolis, olive leaves) through owned apiaries and partnerships.
- Processing and manufacturing natural wellness products under the Comvita brand.
- Distributing products globally through retail channels, e-commerce, and direct sales.
- Leveraging intellectual property and scientific research to develop new products and applications.
- Operating in a vertically integrated manner for key ingredients like Manuka honey, from hive to shelf.
What Industry Does CVNZF Operate In?
Comvita Limited operates within the Consumer Defensive sector, specifically the Packaged Foods industry, but with a distinct focus on natural health and wellness products. This segment is characterized by growing consumer awareness of health and sustainability, driving demand for natural ingredients and functional foods. The global natural health product market is experiencing steady growth, fueled by demographic shifts, rising disposable incomes, and increasing interest in preventative health. Comvita's positioning is unique due to its specialization in Manuka honey, a premium product with specific health attributes, which differentiates it from conventional packaged food companies. The competitive landscape includes other Manuka honey producers, natural supplement companies, and larger consumer goods corporations venturing into the natural wellness space. Comvita leverages its established brand, apiary ownership, and intellectual property to maintain its market position, navigating challenges such as raw material sourcing and product authenticity in a competitive and evolving market.
Who Are CVNZF's Key Customers?
- Health-conscious consumers seeking natural and organic wellness products.
- Individuals interested in the specific health benefits of Manuka honey, propolis, and olive leaf extract.
- Parents looking for natural health solutions for children.
- Consumers in markets across Australia, New Zealand, China, North America, Europe, and other regions.
- Retailers and distributors in the natural health, pharmacy, and grocery sectors.
Key Financial Metrics
Return on assets is -57.0%, showing how much profit it generates from its asset base. Its free cash flow yield is 78.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.80 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -187.1%, the inverse of the P/E and a quick read on earnings relative to price.
Comvita Limited (CVNZF) Valuation Context
Valued at $29.10M, CVNZF is classified as a micro-cap stock. Relative to its peer group, CVNZF's quantitative score of 41/100 is below the peer average of 61/100.
Company Profile
Comvita Limited operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Te Puke, NZ. The company is led by CEO Karl Gradon. CVNZF has traded publicly since 2009.
F-Score 4/9Financial Health
Comvita Limited's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.39 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Comvita Limited revenue of about $212.3M for fiscal 2026, with EPS near $0.08.
CVNZF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Comvita's growth potential, indicating that key stakeholders believe in the company's future.
- Community sentiment has shifted positively, with discussions highlighting the brand's strong market position in the natural health sector.
- New product launches have generated excitement, attracting consumer interest and enhancing brand visibility in a competitive market.
- Sustainability initiatives are resonating well with consumers, positioning Comvita favorably as eco-conscious buying trends gain momentum.
Bear Case
- Concerns about supply chain disruptions have emerged, potentially affecting product availability and operational efficiency.
- Recent market sentiment reflects skepticism regarding the company's ability to maintain growth amid rising competition in the health supplement space.
- Some community discussions highlight worries over profit margins, as increased costs may squeeze profitability in the near term.
- A lack of clear communication from management on future strategies has left investors uncertain about the company's direction and growth plans.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
CVNZF Latest News
-
Comvita Celebrates World Bee Month and World Pollinator Month to Advance Global Bee Conservation and Awareness
Yahoo! Finance: CVNZF News · May 11, 2026
CVNZF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CVNZF.
Price Targets
Wall Street price target analysis for CVNZF.
CVNZF MoonshotScore
What does this score mean?
The MoonshotScore rates CVNZF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Karl Gradon
CEO
Karl Gradon serves as the CEO of Comvita Limited, leading a global team of approximately 400 employees. His leadership is crucial for a company operating internationally in the specialized natural wellness sector. While specific details on his prior career history and educational background are not provided in the source data, his role at the helm of Comvita indicates experience in managing complex operations, international supply chains, and brand development within the consumer goods or health and wellness industries. His strategic direction is instrumental in navigating market dynamics and driving the company's growth initiatives.
Track Record: Under Karl Gradon's leadership, Comvita Limited continues its focus on the creation and distribution of natural wellness products, particularly Manuka honey. While specific achievements or strategic decisions under his tenure are not detailed in the provided information, his role involves overseeing the company's global operations, managing its diverse product portfolio, and steering its market presence across multiple continents. His leadership is key to addressing the company's financial performance, including its current profit margin, and capitalizing on the growing consumer interest in natural health products.
CVNZF OTC Market Information
Comvita Limited trades on the OTC market under the 'OTC Other' tier. This classification indicates that the company does not meet the listing requirements for the higher OTCQX or OTCQB tiers, nor is it listed on a major exchange like NYSE or NASDAQ. Companies in the 'OTC Other' tier typically have less stringent reporting requirements compared to those on national exchanges or even higher OTC tiers. This can result in less publicly available financial and operational information, making comprehensive due diligence more challenging for investors. The 'OTC Other' tier is often associated with smaller companies or those that choose not to pursue more rigorous disclosure standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Limited Transparency:** The 'Unknown' disclosure status and 'OTC Other' tier suggest less public financial and operational information, increasing investment risk.
- **Lower Liquidity:** Reduced trading volume and wider bid-ask spreads can make it challenging to buy or sell shares efficiently.
- **Price Volatility:** Lower liquidity and less information can contribute to greater price fluctuations and potentially more unpredictable stock performance.
- **Regulatory Oversight:** OTC markets generally have less stringent regulatory oversight compared to major exchanges, which may expose investors to higher risks.
- **Limited Analyst Coverage:** OTC stocks often receive minimal or no coverage from institutional analysts, leading to less independent research available for investors.
- Verify the company's latest available financial statements and annual reports, even if less frequent.
- Research management's background and track record beyond what is immediately available.
- Examine the company's business model, competitive advantages, and market position thoroughly.
- Assess the company's compliance with any applicable local or international regulations.
- Investigate any news, press releases, or investor presentations directly from the company.
- Understand the specific risks associated with the 'OTC Other' tier and its implications for trading.
- Evaluate the company's global operations and supply chain resilience given its international footprint.
- **Established History:** Founded in 1974, Comvita has a long operating history, suggesting a stable business foundation.
- **Global Operations:** The company operates across multiple continents, indicating a significant and established international presence.
- **Tangible Assets:** Ownership of apiaries, real estate, and intellectual property demonstrates substantial operational assets.
- **Specific Product Focus:** Specialization in Manuka honey and other natural wellness products indicates a clear business model and market niche.
- **Employee Count:** With 400 employees, Comvita is a sizable company, not a micro-cap shell, which lends credibility.
What Investors Ask About Comvita Limited (CVNZF) — Consumer Defensive
What does Comvita Limited do?
Comvita Limited is a global natural wellness company headquartered in Te Puke, New Zealand, established in 1974. It specializes in the creation and distribution of a diverse range of natural health products. Its core offerings include premium Manuka honey, known for its unique properties, as well as propolis and olive leaf extract. The company also produces specialized honey varieties like Medihoney, gourmet options, elixirs, lozenges, and dedicated lines for oral hygiene and children's health. Beyond products, Comvita manages its own apiaries, holds real estate, and controls significant intellectual property, serving markets across Australia, New Zealand, China, other Asian nations, North America, Europe, the Middle East, and Africa.
What are the main risks for CVNZF?
Comvita Limited faces several key risks. A significant ongoing concern is its reported profit margin of -44.5%, indicating substantial operational or cost challenges that need to be effectively managed to ensure long-term profitability. Environmental factors pose a potential risk, as the company's reliance on bee populations for Manuka honey production makes it vulnerable to climate change, diseases, or pesticide use impacting yields. Supply chain disruptions, both for raw materials and international distribution, present an ongoing challenge that could lead to increased costs or inability to meet market demand. Furthermore, the natural wellness market is highly competitive, with numerous players potentially impacting Comvita's market share and pricing power. Lastly, its trading on the OTC Other tier introduces risks related to lower liquidity, wider bid-ask spreads, and less stringent disclosure requirements, which can affect investor confidence and stock performance.
How does Comvita Limited manage its supply chain for natural products?
Comvita Limited employs a strategic approach to managing its supply chain for natural products, particularly for its flagship Manuka honey. A key aspect of its strategy is vertical integration, which includes the ownership and management of its own apiaries. This direct control over bee populations and honey production allows Comvita to maintain stringent quality standards, ensure the authenticity of its Manuka honey, and mitigate some of the risks associated with external sourcing. For other natural ingredients like propolis and olive leaf extract, the company likely relies on established partnerships and robust sourcing protocols to secure high-quality raw materials. Given its global distribution network, Comvita must also manage complex international logistics to deliver products to markets across Australia, New Zealand, China, North America, Europe, and other regions, balancing efficiency with the preservation of product integrity.
What are the key factors to evaluate for CVNZF?
Comvita Limited (CVNZF) holds an AI score of 41/100 (low). Not financial advice.
How frequently does CVNZF data refresh on this page?
CVNZF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CVNZF's recent stock price performance?
Comvita Limited (CVNZF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established global brand with strong recognition in natural wellness, especially Manuka honey. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CVNZF overvalued or undervalued right now?
Valuing Comvita Limited (CVNZF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CVNZF?
Before investing in Comvita Limited (CVNZF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- No FMP PEER TICKERS were provided in the source data, so the 'competitors' array is empty.
- Specific details on CEO's background and track record beyond his title and company tenure are not available in the provided source data.
- The 'tenureYears' for the CEO is null as no start date was provided.
- The 'Disclosure Status' for OTC classification is explicitly stated as 'Unknown' in the source data.